CAPRICOR THERAPEUTICS
Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Its CAP-1002 is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and COVID-19. The company was founded in 2005 and is headquartered in Los Angeles, California.
CAPRICOR THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.capricor.com
Total Employee:
11+
Status:
Active
Contact:
(310) 358-3200
Email Addresses:
[email protected]
Total Funding:
66.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nucleonics
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Capricor Therapeutics
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Capricor Therapeutics
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Capricor Therapeutics
Cedars Sinai
Cedars Sinai investment in Post-IPO Equity - Capricor Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Post-IPO Equity - Capricor Therapeutics
Broadview Ventures
Broadview Ventures investment in Post-IPO Equity - Capricor Therapeutics
Calmedica
Calmedica investment in Post-IPO Equity - Capricor Therapeutics
Beechwood Ventures
Beechwood Ventures investment in Post-IPO Equity - Capricor Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-02 | Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development |
Official Site Inspections
http://www.capricor.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.98 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Capricor Therapeutics"
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 ...
4 days ago Capricor to host conference call and webcast today at 4:30 p.m. ET SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a …See details»
Capricor Therapeutics - Crunchbase Company Profile
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.See details»
Capricor Therapeutics - Funding, Financials, Valuation & Investors
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.See details»
Capricor Therapeutics Announces for the Treatment of Duchenne …
Jun 25, 2024 Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the …See details»
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 ...
5 days ago About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based …See details»
Capricor Therapeutics Appoints Michael Kelliher to Board of
Sep 6, 2023 Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment …See details»
Capricor Therapeutics to Present Fourth Quarter and Full Year …
Mar 11, 2025 Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the …See details»
Capricor Therapeutics Announces Positive 3-Year Efficacy Results …
Jun 4, 2024 Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the …See details»
SCHEDULE 13G - 01/30/2025 - Capricor Therapeutics, Inc.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect …See details»
Capricor Therapeutics Announces $23 Million Registered Direct …
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome …See details»
WATCH: Capricor Therapeutics – Update on Deramiocel for …
Mar 17, 2025 Capricor Therapeutics recently joined PPMD for a community webinar to provide an update on their novel cell therapy, deramiocel (formerly CAP-1002), targeting …See details»
What is Capricor Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Capricor Therapeutics. Salaries, reviews, and more - all posted by employees working at Capricor Therapeutics.See details»
Capricor Therapeutics, Inc. Management Team | Org Chart
Capricor Therapeutics, Inc. employs 67 employees. The Capricor Therapeutics, Inc. management team includes Officer (Chief Financial Officer), Mark Awadalla (Vice President Clinical …See details»
Earnings call transcript: Capricor Q4 2024 beats EPS forecast, stock …
4 days ago Capricor Therapeutics Inc (CAPR) reported its fourth-quarter 2024 earnings, surpassing EPS expectations with a loss of $0.16 per share compared to the forecasted loss …See details»
10-Q - 11/13/2015 - Capricor Therapeutics, Inc.
Commission File Number: 001-34058 CAPRICOR THERAPEUTICS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware (State or other jurisdiction of incorporation or …See details»
Exosomes Clinical Trials and Studies: EMA, PDMA, FDA Approvals ...
Capricor’s (CAP-1002) is based on cardiosphere-derived cells, or CDCs, a cardiac-derived cell therapy that was first identified in the academic laboratory of Capricor’s scientific founder, Dr. …See details»
On the Couch | What makes Capricorn unique?
Our past, present and future Capricorn leaders share their thoughts on what makes Capricorn unique. While all have slightly different responses, they all agree that it comes back to our …See details»
Capricor Therapeutics Reports Fourth Quarter and Full Year
4 days ago About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based …See details»
Capricorn Organization & Efficiency - InnerSelf.com
Capricorn, Aquarius, and Pisces are the astrological signs which sup and sip on the essence of life served at winter's table. As the representatives of the final quarter of the zodiacal year, …See details»
Capricorn Organization & Efficiency - InnerSelf.com
Capricorn, symbolized by the goat whose patient, steady climb is rewarded with a view from the loftiest mountain top, is governed by Saturn, the solar system's ringed giant. This sign begins …See details»